Assessment of silent brain injury in patients undergoing elective percutaneous coronary intervention due to chronic total occlusion

References

• Danek BA, Karatasakis A, Karmpaliotis D, et al. Development and validation of a scoring system for predicting periprocedural complications during percutaneous coronary interventions of chronic total occlusions: the prospective global registry for the study of chronic total occlusion intervention (PROGRESS CTO) complications score. J Am Heart Assoc. 2016;5(10):e004272.
   PubMed Web of Science ®Google Scholar
• Christopoulos G, Kandzari DE, Yeh RW, et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO (prospective global registry for the study of chronic total occlusion intervention) score. JACC Cardiovasc Interv. 2016;9(1):1–9.
   PubMed Web of Science ®Google Scholar
• Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (multicenter CTO registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv. 2011;4(2):213–221.
   PubMed Web of Science ®Google Scholar
• Siachos T, Vanbakel A, Feldman DS, et al. Silent strokes in patients with heart failure. J Card Fail. 2005;11(7):485–489.
   PubMed Web of Science ®Google Scholar
• Kase CS, Wolf PA, Chodosh EH, et al. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study. Stroke. 1989;20(7):850–852.
   PubMed Web of Science ®Google Scholar
• Liebetrau M, Steen B, Hamann GF, et al. Silent and symptomatic infarcts on cranial computerized tomography in relation to dementia and mortality: a population-based study in 85-year-old subjects. Stroke. 2004;35(8):1816–1820.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Okada K, Koide H, et al. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997;28(10):1932–1939.
   PubMed Web of Science ®Google Scholar
• Bokura H, Kobayashi S, Yamaguchi S, et al. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis. 2006;15(2):57–63.
   PubMedGoogle Scholar
• Yamashita H, Fujikawa T, Yanai I, et al. Cognitive dysfunction in recovered depressive patients with silent cerebral infarction. Neuropsychobiology. 2002;45(1):12–18.
   PubMed Web of Science ®Google Scholar
• Wright CB, Festa JR, Paik MC, et al. White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke. 2008;39(3):800–805.
   PubMed Web of Science ®Google Scholar
• Avdibegović E, Bećirović E, Selimbasić Z, et al. Cerebral cortical atrophy and silent brain infarcts in psychiatric patients. Psychiatr Danub. 2007;19(1–2):49–55.
   PubMed Web of Science ®Google Scholar
• Price TR, Manolio TA, Kronmal RA, et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults: the cardiovascular health study. Stroke. 1997;28(6):1158–1164.
   PubMed Web of Science ®Google Scholar
• Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–2089.
   PubMed Web of Science ®Google Scholar
• Brouns R, Vil BD, Cras P, et al. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients. Clin Chem. 2010;56(3):451–458.
   PubMed Web of Science ®Google Scholar
• Isgrò MA, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:125–143.
   PubMed Web of Science ®Google Scholar
• Anand N, Stead LG. Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc Dis. 2005;20(4):213–219.
   PubMed Web of Science ®Google Scholar
• Barone FC, Clark RK, Price WJ, et al. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res. 1993;623(1):77–82.
   PubMed Web of Science ®Google Scholar
• Kurakina AS, Semenova TN, Guzanova EV, et al. Prognostic value of investigating neuron-specific enolase in patients with ischemic stroke. Sovrem Tekhnologii Med. 2021;13(2):68–72.
   PubMed Web of Science ®Google Scholar
• Missler U, Wiesmann M, Friedrich C, et al. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997;28(10):1956–1960.
   PubMed Web of Science ®Google Scholar
• Hassell MEC, Nijveldt R, Roos YBW, et al. Silent cerebral infarcts associated with cardiac disease and procedures. Nat Rev Cardiol. 2013;10(12):696–706.
   PubMed Web of Science ®Google Scholar
• Sun X, Lindsay J, Monsein LH, et al. Silent brain injury after cardiac surgery: a review: cognitive dysfunction and magnetic resonance imaging diffusion-weighted imaging findings. J Am Coll Cardiol. 2012;60(9):791–797.
   PubMedGoogle Scholar
• Ghanem A, Müller A, Nähle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55(14):1427–1432.
   PubMed Web of Science ®Google Scholar
• Gaita F, Caponi D, Pianelli M, et al. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism?: magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation. 2010;122(17):1667–1673.
   PubMed Web of Science ®Google Scholar
• Cho S-M, Deshpande A, Pasupuleti V, et al. Radiographic and clinical brain infarcts in cardiac and diagnostic procedures: a systematic review and meta-analysis. Stroke. 2017;48(10):2753–2759.
   PubMed Web of Science ®Google Scholar
• Goksuluk H, Gulec S, Ozcan OU, et al. Usefulness of neuron-specific enolase to detect silent neuronal ischemia after percutaneous coronary intervention. Am J Cardiol. 2016;117(12):1917–1920.
   PubMed Web of Science ®Google Scholar
• Aykan A, Zehir R, Karabay CY, et al. Contrast-induced monoplegia following coronary angioplasty with iopromide. Kardiol Pol. 2012;70(5):499–500.
   PubMed Web of Science ®Google Scholar
• Murai M, Hazui H, Sugie A, et al. Asymptomatic acute ischemic stroke after primary percutaneous coronary intervention in patients with acute coronary syndrome might be caused mainly by manipulating catheters or devices in the ascending aorta, regardless of the approach to the coronary artery. Circ J. 2008;72(1):51–55.
   PubMed Web of Science ®Google Scholar
• Lund C, Nes RB, Ugelstad TP, et al. Cerebral emboli during left heart catheterization may cause acute brain injury. Eur Heart J. 2005;26(13):1269–1275.
   PubMed Web of Science ®Google Scholar
• Tokarek T, Dziewierz A, Plens K, et al. Comparison of safety and effectiveness between the right and left radial artery approach in percutaneous coronary intervention. Rev Esp Cardiol. 2022;75(2):119–128.
   PubMed Web of Science ®Google Scholar
• Göksülük H, Güleç S, Özyüncü N, et al. Comparison of frequency of silent cerebral infarction after coronary angiography and stenting with transradial versus transfemoral approaches. Am J Cardiol. 2018;122(4):548–553.
   PubMed Web of Science ®Google Scholar
• Dziewierz A, Siudak Z, Tokarek T, et al. Determinants of stroke following percutaneous coronary intervention in acute myocardial infarction (from ORPKI polish national registry). Int J Cardiol. 2016;223:236–238.
   PubMed Web of Science ®Google Scholar
• Tokarek T, Dziewierz A, Plens K, et al. Radial approach expertise and clinical outcomes of percutanous coronary interventions performed using femoral approach. J Clin Med. 2019;8(9):1484.
   PubMed Web of Science ®Google Scholar
• Tugcu A, Jin Z, Homma S, et al. Atherosclerotic plaques in the aortic arch and subclinical cerebrovascular disease. Stroke. 2016;47(11):2813–2819.
   PubMed Web of Science ®Google Scholar
• Rakowski T, Węgiel M, Siudak Z, et al. Prevalence and predictors of coronary artery perforation during percutaneous coronary interventions (from the ORPKI national registry in Poland). Am J Cardiol. 2019;124(8):1186–1189.
   PubMed Web of Science ®Google Scholar
• Ramirez G, O’Neill WM, Lambert R, et al. Cholesterol embolization: a complication of angiography. Arch Intern Med. 1978;138(9):1430–1432.
   PubMedGoogle Scholar
• Dávila-Román VG, Barzilai B, Wareing TH, et al. Atherosclerosis of the ascending aorta. Prevalence and role as an independent predictor of cerebrovascular events in cardiac patients. Stroke. 1994;25(10):2010–2016.
   PubMed Web of Science ®Google Scholar
• Karalis DG, Quinn V, Victor MF, et al. Risk of catheter-related emboli in patients with atherosclerotic debris in the thoracic aorta. Am Heart J. 1996;131(6):1149–1155.
   PubMed Web of Science ®Google Scholar
• Aykan AÇ, Gökdeniz T, Bektaş H, et al. Assessment of silent neuronal injury following coronary angiography and intervention in patients with acute coronary syndrome. Clin Appl Thromb Hemost. 2016;22(1):52–59.
   PubMed Web of Science ®Google Scholar
• Deveci OS, Celik AI, Ikikardes F, et al. The incidence and the risk factors of silent embolic cerebral infarction after coronary angiography and percutaneous coronary interventions. Angiology. 2016;67(5):433–437.
   PubMed Web of Science ®Google Scholar
• Spina R, Simon N, Markus R, et al. Contrast-induced encephalopathy following cardiac catheterization. Catheter Cardiovasc Interv. 2017;90(2):257–268.
   PubMed Web of Science ®Google Scholar
• Rönnemaa T, Laakso M, Pyörälä K, et al. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb. 1991;11(1):80–90.
   PubMedGoogle Scholar
• Pyöräla K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2(2):131–141.
   PubMedGoogle Scholar
• Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol. 2004;44(12):2293–2300.
   PubMed Web of Science ®Google Scholar
• Ravipati G, Aronow WS, Ahn C, et al. Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellitus. Am J Cardiol. 2006;97(7):968–969.
   PubMed Web of Science ®Google Scholar
• Oh S-H, Lee J-G, Na S-J, et al. Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level. Arch Neurol. 2003;60(1):37–41.
   PubMedGoogle Scholar
• Brown WR, Moody DM, Challa VR, et al. Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli. Stroke. 2000;31(3):707–713.
   PubMed Web of Science ®Google Scholar
• Gupta A, Giambrone AE, Gialdini G, et al. Silent brain infarction and risk of future stroke: a systematic review and meta-analysis. Stroke. 2016;47(3):719–725.
   PubMed Web of Science ®Google Scholar
• Hamon M, Gomes S, Clergeau M-R, et al. Risk of acute brain injury related to cerebral microembolism during cardiac catheterization performed by right upper limb arterial access. Stroke. 2007;38(7):2176–2179.
   PubMed Web of Science ®Google Scholar
• Haque A, Polcyn R, Matzelle D, et al. New insights into the role of neuron-specific enolase in neuro-inflammation, neurodegeneration, and neuroprotection. Brain Sci. 2018;8(2):33.
   PubMed Web of Science ®Google Scholar